Julius Clinical Research BV

Julius Clinical Research BV is a company in Zeist, Netherlands that has taken part in 9 EU-funded projects since 2013, receiving €19.2M in EU funding.

EU funding received€19.2M
EU projects9
As coordinator0
Running now3
First EU project2013
Latest project2026
CountryNetherlands
EU registration (PIC)988243858
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Julius Clinical Research BV's own share of each project, not the project's full budget.

  • Horizon 2020€14.8M · 5 projects
  • Horizon Europe€2.8M · 3 projects
  • FP7 (2007 to 2013)€1.6M · 1 project

Projects

9 EU-funded projects, newest first. Each links to the official record.

  • EDICTAssociated partner

    Advancing Equity, Diversity and Inclusion in Clinical Trials

    Horizon Europe · 2026–2030 · Project on CORDIS ↗

  • GRIPonMASHPartner

    GRIP on MASH: Global Research Initiative for Patient Screening on MASH

    Horizon Europe · 2023–2027 · Project on CORDIS ↗

    €2.0Mtheir share
  • PREFERABLE-IIPartner

    PREFERABLE-II - Personalised Exercise-Oncology for improvement of supportive care: a super umbrella trial to demonstrate the (cost)effectiveness of live-remote exercise in cancer survivors

    Horizon Europe · 2022–2027 · Project on CORDIS ↗

    €790ktheir share
  • COVID-REDPartner

    COVID-19 infections - Remote Early Detection

    Horizon 2020 · 2020–2022 · Project on CORDIS ↗

    €2.0Mtheir share
  • Trials@HomePartner

    Trials@Home: Center of Excellence – Remote Decentralised Clinical Trials

    Horizon 2020 · 2019–2025 · Project on CORDIS ↗

    €6.5Mtheir share
  • PREFERABLEPartner

    Project on Exercise for Fatigue Eradication in Advanced Breast cancer to improve quality of life

    Horizon 2020 · 2019–2024 · Project on CORDIS ↗

    €724ktheir share
  • CONVINCEPartner

    The Comparison of High-Dose Heamodiafiltration (HDF) versus Haemodialyse

    Horizon 2020 · 2018–2023 · Project on CORDIS ↗

    €2.6Mtheir share
  • HIT-CFPartner

    Personalised Treatment For Cystic Fibrosis Patients With Ultra-rare CFTR Mutations (and beyond)

    Horizon 2020 · 2018–2025 · Project on CORDIS ↗

    €2.9Mtheir share
  • COMBACTE-NETPartner

    Combatting Bacterial Resistance in Europe

    FP7 (2007 to 2013) · 2013–2021 · Project on CORDIS ↗

    €1.6Mtheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • alcohols
  • antibiotic resistance
  • bacteriology
  • coronaviruses
  • employment
  • health care sciences
  • health care services
  • hepatology
  • kidney diseases
  • medical ethics
  • mortality
  • mutation
  • obesity
  • oncology

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships. Official website ↗

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime